Daniel Omstead is listed as a director on 7 SEC Form D filings by 2 issuers between Mar 2015 and Jun 2017: Euthymics Bioscience, Inc. (Cambridge, MA — biotechnology — 2017; $28M reported sold to 7 investors) and Neurovance, Inc. (Cambridge, MA — biotechnology — 2015–2017; $26.5M reported sold to 7 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $54.5M sold in total.
Listed alongside Albert L. Sokol (7 shared filings), Anthony A. McKinney (7 shared filings), Brigitte Smith (7 shared filings), Campbell Murray (7 shared filings), Paul Weiss (7 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Daniel. Each name links to their own page.
All 2 issuers belong to the sponsor group Euthymics (3 issuers, $882K reported sold, 2010–2017).
What this means A sponsor group is one team that sets up a new company for each deal. Euthymics has 3 companies on file and $882K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 3 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 7 public filings for Daniel Omstead and found 7 differences: 3 court cases name Daniel Omstead; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.